Syneos Health Opens New Hyderabad Hub, Positions City as Global Centre for AI and Clinical Innovation

HYDERABAD: Syneos Health has opened a new Hyderabad hub focused on innovation, artificial intelligence and advanced clinical solutions, further strengthening the city’s position as a major destination for global healthcare technology and life sciences operations.

The company describes the Hyderabad facility as a strategic AI Hub bringing together scientific expertise, biopharmaceutical knowledge and engineering capabilities to develop and deploy AI-powered solutions across the healthcare and life sciences sector.

The new facility is being positioned as Syneos Health’s largest office in Asia and its third-largest office globally, according to the company’s Hyderabad team. The opening marks a significant expansion of the company’s presence in a city that has emerged as an important intersection of life sciences, data engineering and advanced analytics.

Hyderabad Hub to Focus on AI-Powered Healthcare

Syneos Health’s new Hyderabad hub is designed to support the development of production-ready artificial intelligence solutions for clinical development, patient safety and commercialisation.

According to Syneos Health, the hub is being built around technology, data and AI excellence, with teams working alongside clinicians, safety scientists and commercial specialists. The objective is to use AI within real-world healthcare workflows rather than treating it only as an experimental technology.

The company says its Hyderabad AI teams are working on applications including AI-driven clinical protocol design, predictive site selection, intelligent assistants, pharmacovigilance automation, signal detection and medical review.

The hub is also expected to support generative AI and AI-agent applications across life sciences, including systems that can navigate scientific knowledge and assist decision-making across clinical and commercial workflows.

From Clinical Trials to Patient Safety

The technology being developed in Hyderabad is intended to cover multiple stages of the biopharmaceutical lifecycle.

• Clinical development: AI-assisted protocol design, patient recruitment, study oversight and predictive analytics.
• Pharmacovigilance: Natural language processing and large language models to accelerate case processing and support safety-signal detection.
• Clinical surveillance: Multimodal analytics to identify treatment patterns and patient needs.
• Generative AI: Retrieval-augmented systems and domain-specific AI agents for scientific and commercial decision-making.
• Commercialisation: AI and analytics supporting commercial strategy, customer engagement and market access.

Syneos Health says its AI approach is designed for regulated, high-stakes environments, with human expertise remaining central to the way the technology is deployed.

Growing AI Talent Base in Hyderabad

The company is also expanding its Hyderabad workforce across several specialised technology and data roles.

Syneos Health’s current Hyderabad AI hiring requirements include GenAI engineers, prompt specialists, MLOps and platform engineers, data engineers, data scientists, AI product managers, technical programme managers, responsible AI and compliance specialists, quality engineers and enterprise architects.

The company’s careers portal currently lists multiple Hyderabad openings across safety and pharmacovigilance, data, technology, quality, cybersecurity, statistical programming and business operations. Recent postings include roles such as Data Scientist, Validation & QA Analyst, Safety & PV Specialist, Senior Transformation Analyst and Cyber Resiliency Senior Technical Analyst.

Hyderabad Becomes a Strategic Location for Syneos Health

The new hub builds on Syneos Health’s existing Hyderabad operations. The company’s official office-location directory lists its Hyderabad presence at Raheja Mindspace in HITEC City.

The expansion also comes as Hyderabad continues to attract global healthcare, pharmaceutical, technology and life sciences companies looking to combine access to skilled talent with a strong ecosystem in technology and research.

Syneos Health’s own description of the Hyderabad AI Hub highlights the city’s growing convergence of life sciences, data engineering and advanced analytics as one of the reasons for establishing the facility as a dedicated technology and innovation centre.

AI Increasingly Central to Syneos Health’s Global Strategy

The Hyderabad opening is part of a wider push by Syneos Health to integrate AI into clinical development and commercialisation.

The company says it is currently applying AI and machine learning across areas including clinical development, patient recruitment, study oversight, commercial strategy, customer engagement and market access.

Syneos Health’s global AI platform currently highlights more than 280 AI agents advancing workflows and reports improvements including faster scientific research and moving certain data-capture-to-insight processes from days to hours.

Hyderabad Takes Centre Stage in Clinical Technology

The opening of the new hub comes at a time when Hyderabad is increasingly positioning itself beyond its traditional identity as an IT and software services centre.

The city’s combination of pharmaceutical companies, clinical research organisations, biotechnology businesses, technology talent and data-science capabilities is creating opportunities for global companies to establish specialised healthcare technology operations.

Syneos Health’s Hyderabad hub brings these sectors together, combining clinical and scientific expertise with AI, data engineering and software capabilities.

The company has also described the hub as a growth engine for innovators, with an emphasis on attracting and developing AI talent while delivering technology for global biopharmaceutical customers.

A New Milestone for Hyderabad’s Global Healthcare Ecosystem

With the new facility positioned as Syneos Health’s largest office in Asia and third-largest globally, the expansion represents another major corporate commitment to Hyderabad.

More importantly, the focus of the hub reflects the changing nature of global healthcare operations. AI is increasingly being used to improve how clinical trials are designed and managed, how patient and safety data is analysed, and how pharmaceutical companies make decisions.

For Hyderabad, the development adds another high-value global technology operation to the city’s growing life sciences and AI ecosystem.